Journal of Clinical Oncology
Publication Venue For
Cost-Effectiveness of First-Line Versus Second-Line Use of Daratumumab in Older, Transplant-Ineligible Patients With Multiple Myeloma.
Favorable Trisomies and ETV6-RUNX1 Predict Cure in Low-Risk B-Cell Acute Lymphoblastic Leukemia: Results From Children's Oncology Group Trial AALL0331.
NF106: A neurofibromatosis clinical trials consortium phase II trial of the MEK inhibitor mirdametinib (PD-0325901) in adolescents and adults with NF1-related plexiform neurofibromas
TBCRC 048: Phase II Study of Olaparib for Metastatic Breast Cancer and Mutations in Homologous Recombination-Related Genes
Updated breast cancer surveillance recommendations for female survivors of childhood, adolescent, and young adult cancer from the international guideline harmonization group
Survival in Patients with Brain Metastases: Summary Report on the Updated Diagnosis-Specific Graded Prognostic Assessment and Definition of the Eligibility Quotient
Children's oncology group AALL0434: A phase III randomized clinical trial testing nelarabine in newly diagnosed t-cell acute lymphoblastic leukemia
Chronic comorbidities among survivors of adolescent and young adult cancer
Impact of intrathecal triple therapy versus intrathecal methotrexate on disease-free survival for high-risk B-lymphoblastic leukemia: Children⇔s Oncology Group Study AALL1131
Clinical and genetic risk prediction of cognitive impairment after blood or marrow transplantation for hematologic malignancy
Clinical Cancer Advances 2020: Annual report on progress against cancer from the American Society of Clinical oncology
MK-2206 and standard neoadjuvant chemotherapy improves response in patients with human epidermal growth factor receptor 2–positive and/or hormone receptor–negative breast cancers in the I-SPY 2 trial
Forging a new frontier: Providing palliative care to people with cancer in rural and remote areas
Outcome in children with standard-risk b-cell acute lymphoblastic leukemia: Results of children's oncology group trial aall0331
Prevalence and Predictors of Frailty in Childhood Cancer Survivors and Siblings: A Report From the Childhood Cancer Survivor Study
Patient-level factors associated with lack of health care provider recommendation for the human papillomavirus vaccine among young cancer survivors
Total body irradiation and risk of breast cancer after blood or marrow transplantation: A blood or marrow transplantation survivor study report
Clofarabine can replace anthracyclines and etoposide in remission induction therapy for childhood acute myeloid leukemia: The AML08 multicenter, randomized phase III trial
Impact of travel time on health care costs and resource use by phase of care for older patients with cancer
Bridging the data-free zone: Decision making for older adults with cancer
Hematopoietic stem-cell transplantation does not improve the poor outcome of children with hypodiploid acute lymphoblastic leukemia: A report from children's oncology group
Improved CNS control of childhood acute lymphoblastic leukemia without cranial irradiation: St Jude Total Therapy Study 16
Multicenter, prospective, phase II and biomarker study of high-dose bevacizumab as induction therapy in patients with neurofibromatosis type 2 and progressive vestibular schwannoma
Subsequent breast cancer in female childhood cancer survivors in the St Jude Lifetime Cohort Study (SJLIFE)
Subsequent neoplasms after a primary tumor in individuals with neurofibromatosis type 1
Survival by race and ethnicity in pediatric and adolescent patients with hodgkin lymphoma: A children’s oncology group study
Survival outcomes of younger patients with mantle cell lymphoma treated in the rituximab era
End-of-life care intensity in patients undergoing allogeneic hematopoietic cell transplantation: A population-level analysis
Should we be talking about guidelines with patients? A qualitative analysis in metastatic breast cancer.
Trust but verify: Patterns of obtaining health information and the role of physician trust in decision-making amongst patients with metastatic breast cancer.
Improved survival for children and young adults with t-lineage acute lymphoblastic leukemia: Results from the children's oncology Group AALL0434 methotrexate randomization
Dasatinib plus intensive chemotherapy in children, adolescents, and young adults with philadelphia chromosome–positive acute lymphoblastic leukemia: Results of children’s oncology group trial AALL0622
Surveillance for late effects in childhood cancer survivors
Reply to E. Parkin et al
New-onset cardiovascular morbidity in older adults with stage i to III colorectal cancer
TP53 germline variations influence the predisposition and prognosis of b-cell acute lymphoblastic leukemia in children
Cognitive functioning after hematopoietic cell transplantation for hematologic malignancy: Results from a prospective longitudinal study
What is the role of symptom management and patient-reported outcomes in adherence to aromatase inhibitors?
Effects of aerobic and resistance exercise on metabolic syndrome, sarcopenic obesity, and circulating biomarkers in overweight or obese survivors of breast cancer: A randomized controlled trial
Selective inhibition of nuclear export with oral selinexor for treatment of relapsed or refractory multiple myeloma
Development and validation of nomograms predictive of overall and progression-free survival in patients with oropharyngeal cancer
Prevalence and predictors of sperm banking in adolescents newly diagnosed with cancer: Examination of adolescent, parent, and provider factors influencing fertility preservation outcomes
Clinical and genetic risk prediction of subsequent CNS tumors in survivors of childhood cancer: A report fromthe COG ALTE03N1 study
Factors associated with participating in formal support services among family caregivers of older adults with poor-prognosis cancers.
Human papillomavirus vaccination rates in young cancer survivors
Arsenic trioxide consolidation allows anthracycline dose reduction for pediatric patients with acute promyelocytic leukemia: Report from the children’s oncology group phase III historically controlled trial AAML0631
Randomized phase II study of azacitidine alone or in combination with lenalidomide or with vorinostat in higher-risk myelodysplastic syndromes and chronic myelomonocytic leukemia: north American intergroup study swog s1117
Impact of initial CSF findings on outcome among patients with National Cancer Institute standard- and high-risk B-cell acute lymphoblastic leukemia: A report from the Children’s Oncology Group
Mercaptopurine ingestion habits, red cell thioguanine nucleotide levels, and relapse risk in children with acute Lymphoblastic Leukemia: A report from the children’s Oncology group study AALL03N1
Clonal hematopoiesis associated with adverse outcomes after autologous stem-cell transplantation for lymphoma
High Frequency and Poor Outcome of Philadelphia Chromosome-Like Acute Lymphoblastic Leukemia in Adults
Impact of intensity-modulated radiation therapy technique for locally advanced non-small-cell lung cancer: A secondary analysis of the NRG oncology RTOG 0617 randomized clinical trial
Differences between women's preferred and actual experience with 'shared decision-making': A mixed method study
Phase I study of selinexor, a selective inhibitor of nuclear export, in combination with fludarabine and cytarabine, in pediatric relapsed or refractory acute leukemia
Comprehensive geriatric assessment-guided therapy does improve outcomes of older patients with advanced lung cancer
Differences between women’s preferred and actual experience with ‘shared decision-making’: A mixed method study.
Differences in self-care behaviors by varying levels of caregiving intensity, performance, and well-being among family caregivers of patients with high-mortality cancer.
What’s in the ‘special sauce’ of protocol-driven outpatient palliative care consultations?
Recommendations for premature ovarian insufficiency surveillance for female survivors of childhood, adolescent, and young adult cancer: A report from the International Late Effects of Childhood Cancer Guideline Harmonization Group in collaboration with the PanCareSurFup consortium
Changes in clinical context for Kaposi's sarcoma and non-Hodgkin lymphoma among people with HIV infection in the United States
Reply to F. Felix et al and M.F. Fay et al
Therapeutic impact of cytoreductive surgery and irradiation of posterior fossa ependymoma in the molecular era: A retrospective multicohort analysis
Dexamethasone and high-dose methotrexate improve outcome for children and young adults with high-risk B-acute lymphoblastic leukemia: A report from children's oncology group study AALL0232
Prognostic Impact of 21-Gene Recurrence Score in Patients With Stage IV Breast Cancer: TBCRC 013
Scoring system prognostic of outcome in patients undergoing allogeneic hematopoietic cell transplantation for myelodysplastic syndrome
Cardiovascular disease risk profiles in survivors of adolescent and young adult (AYA) cancer: The kaiser permanente AYA cancer survivors study
Racial/ethnic differences in adverse outcomes among childhood cancer survivors: The childhood cancer survivor study
Association of Human Papillomavirus and p16 Status with Outcomes in the IMCL-9815 Phase III Registration Trial for Patients with Locoregionally Advanced Oropharyngeal Squamous Cell Carcinoma of the Head and Neck Treated with Radiotherapy with or Without Cetuximab
Cardiovascular disease among survivors of adult-onset cancer: A community-based retrospective cohort study
Final Results of the Sunbelt Melanoma trial: A multi-institutional prospective randomized phase III study evaluating the role of adjuvant high-dose interferon alfa-2b and completion lymph node dissection for patients staged by sentinel lymph node biopsy
Reply to W. Hryniuk et al
Breast cancer risk in childhood cancer survivors without a history of chest radiotherapy: A report from the childhood cancer survivor study
CELF4 variant and anthracycline-related cardiomyopathy: A children's oncology group genome-wide association study
Chemotherapy for muscle-invasive bladder cancer: Better late than never?
Does valproic acid or levetiracetam improve survival in glioblastoma? A pooled analysis of prospective clinical trials in newly diagnosed glioblastoma
A right atrial mass: "more than meets the eye"
Pattern of CA19-9 response to neoadjuvant chemotherapy in locally advanced, borderline resectable pancreatic cancer to predict progression.
Changes in biomarkers and DNA methylation in breast cancer survivors enrolled in the ENERGY weight loss trial: A pilot study.
Physical activity communication between oncology providers and patients with early stage breast, colon or prostate cancer.
Vascular tumor burden as a new quantitative CT imaging biomarker for predicting metastatic RCC response to antiangiogenic therapy.
Reply to R.A. Ferrer et al and B.W. Corn
Impact of tailored education on awareness of personal risk for therapy-related complications among childhood cancer survivors
Recommendations for obesity clinical trials in cancer survivors: American Society of Clinical Oncology statement
Improved outcomes after autologous hematopoietic cell transplantation for light chain amyloidosis: A center for international blood and marrow transplant research study
Evaluation of the safety and benefit of phase I oncology trials for patients with primary CNS tumors
Results of the exercise and nutrition to enhance recovery and good health for you (ENERGY) trial: A behavioral weight loss intervention in overweight or obese breast cancer survivors
Trends toward declining aggressive care at end of life among older cancer patients in the Deep South
Collaborative research in childhood cancer survivorship: The current landscape
Late mortality after dexrazoxane treatment: A report from the Children's Oncology Group
Reduction in late mortality among 5-year survivors of childhood cancer: A report from the Childhood Cancer Survivor Study (CCSS).
Disparities in hospice use among patients with cancer in the Deep South
Identifying sources of distress in patients with breast cancer
EMERGE: A randomized phase II study of the antibody-drug conjugate glembatumumab vedotin in advanced glycoprotein NMB - Expressing breast cancer
Fewer scans, better care
Long-term pulmonary function in survivors of childhood cancer
Benefits of early versus delayed palliative care to informal family caregivers of patients with advanced cancer: Outcomes from the ENABLE III randomized controlled trial
Early versus delayed initiation of concurrent palliative oncology care: Patient outcomes in the ENABLE III randomized controlled trial
Inherited NUDT15 variant is a genetic determinant of mercaptopurine intolerance in children with acute lymphoblastic leukemia
Phase III open-label randomized study of cytarabine in combination with amonafide L-malate or daunorubicin as induction therapy for patients with secondary acute myeloid leukemia
Benefits of Early versus Later Palliative Care to Informal Family Caregivers of Persons with Advanced Cancer: Outcomes from the ENABLE III Randomized Clinical Trial.
Pharmacokinetic and pharmacodynamic properties of calaspargase pegol Escherichia coli L-asparaginase in the treatment of patients with acute lymphoblastic leukemia: Results from children's oncology group study AALL07P4
Phase III study of iniparib plus gemcitabine and carboplatin versus gemcitabine and carboplatin in patients with metastatic triple-negative breast cancer
Phase I/II study of the antibody-drug conjugate glembatumumab vedotin in patients with locally advanced or metastatic breast cancer
American Society of Clinical Oncology position statement on obesity and cancer
Guiding lay navigation using the distress thermometer.
Impact of care at NCI Comprehensive Cancer Centers (NCICCC) on cancer outcome: Results from a population-based study.
Comorbidity-age index: A clinical measure of biologic age before allogeneic hematopoietic cell transplantation
Randomized phase III trial of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III to IV head and neck carcinoma: RTOG 0522
Breast cancer after chest radiation therapy for childhood cancer
Prolonged administration of azacitidine with or without entinostat for myelodysplastic syndrome and acute myeloid leukemia with myelodysplasia-related changes: Results of the US Leukemia intergroup trial E1905
Cytogenetic prognostication within medulloblastoma subgroups
Hyaluronan synthase 3 variant and anthracycline-related cardiomyopathy: A report from the children's oncology group
Immediate vs delayed initiation of concurrent palliative oncology care: Patient outcomes of the ENABLE III randomized controlled trial
Epigenetics meets genetics in acute myeloid leukemia: Clinical impact of a novel seven-gene score
Ototoxicity in children with high-risk neuroblastoma: Prevalence, risk factors, and concordance of grading scales - A report from the Children's Oncology Group
Autologous or reduced-intensity conditioning allogeneic hematopoietic cell transplantation for chemotherapy-sensitive mantle-cell lymphoma: Analysis of transplantation timing and modality
Comprehensive kinase profiling to classify clear cell (cc)-renal cell carcinoma (RCC).
Integrated comprehensive high-throughput kinomics profiling and whole exome sequencing of penile squamous cell cancer (PSCC).
Association between the prevalence of symptoms and health-related quality of life in adult survivors of childhood cancer: A report from the st jude lifetime cohort study
Impact of care at NCI comprehensive cancer centers (NCICCC) on outcomes in children, adolescents, and young adults (AYA) with central nervous system tumors (CNSt).
Intrachromosomal amplification of chromosome 21 is associated with inferior outcomes in children with acute lymphoblastic leukemia treated in contemporary standard-risk children's oncology group studies: A report from the children's oncology group
Phase III randomized trial comparing the efficacy of cediranib as monotherapy, and in combination with lomustine, versus lomustine alone in patients with recurrent glioblastoma
Hematopoietic cell transplantation for systemic mature T-cell non-hodgkin lymphoma
Subgroup-specific prognostic implications of TP53 mutation in medulloblastoma
Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma and methylated O(6)-methylguanine-DNA methyltransferase (MGMT) gene promoter: Key results of the multicenter, randomized, open-label, controlled, phase III CENTRIC study.
Reply to K. Orendi et al
Clinical role of micrornas in cytogenetically normal acute myeloid leukemia: MiR-155 Upregulation independently identifies high-risk patients
To your health: How does the latest research on alcohol and breast cancer inform clinical practice?
Patient benefit from salvage radiation for prostate cancer.
American society of clinical oncology statement: Achieving high-quality cancer survivorship care
Extended neoadjuvant chemotherapy (CT) in borderline resectable pancreas cancer (BRPC): Is preoperative chemoradiation (CRT) essential?
Role of biliary CEACAM6 as a biomarker for cholangiocarcinoma.
Quality of life among long-term survivors of non-Hodgkin lymphoma: A follow-up study
A phase II, randomized, open label trial of preoperative letrozole versus letrozole (LET) in combination with bevacizumab (BEV) in post-menopausal women with newly diagnosed stage II/III breast cancer
An open label, randomized, phase II trial of nanoparticle albumin-bound paclitaxel (nab-PAC) with or without the anti-death receptor 5 monoclonal antibody tigatuzumab in patients with metastatic triple negative breast cancer
Prognostic significance of the European LeukemiaNet standardized system for reporting cytogenetic and molecular alterations in adults with acute myeloid leukemia
Yield of Screening for Long-Term Complications Using the Children's Oncology Group Long-Term Follow-Up Guidelines
The effect of care at NCI comprehensive cancer centers on disparities in outcome in adolescents and young adults (AYAs) with cancer.
Failure to rescue as a source of variation in hospital mortality for ovarian cancer
Troublesome symptoms in cancer survivors: Fatigue, insomnia, neuropathy, and pain
Reply to C.D. Atkins
Pathologic complete response predicts recurrence-free survival more effectively by cancer subset: Results from the I-SPY 1 TRIAL - CALGB 150007/150012, ACRIN 6657
Reply to M.C. Chamberlain et al
RUNX1 mutations are associated with poor outcome in younger and older patients with cytogenetically normal acute myeloid leukemia and with distinct gene and microRNA expression signatures
Hyperfractionated or accelerated radiotherapy in lung cancer: An individual patient data meta-analysis
Phase II trial of trastuzumab in combination with cytotoxic chemotherapy for treatment of metastatic osteosarcoma with human epidermal growth factor receptor 2 overexpression: A report from the children's oncology group
Reach out to enhance wellness home-based diet-exercise intervention promotes reproducible and sustainable long-term improvements in health behaviors, body weight, and physical functioning in older, overweight/obese cancer survivors
New insights into the risk of breast cancer in childhood cancer survivors treated with chest radiation: A report from the Childhood Cancer Survivor Study (CCSS) and the Women's Environmental Cancer and Radiation Epidemiology (WECARE) Study.
Nonadherence to oral mercaptopurine and risk of relapse in hispanic and non-hispanic white children with acute lymphoblastic leukemia: A report from the Children's Oncology Group
Tobacco smoking and increased risk of death and progression for patients with p16-positive and p16-negative oropharyngeal cancer
Anthracycline-related cardiomyopathy after childhood cancer: Role of polymorphisms in carbonyl reductase genes - A report from the Children's Oncology Group
Age-related prognostic impact of different types of DNMT3A mutations in adults with primary cytogenetically normal acute myeloid leukemia
Reply to J. Lagro et al
Neoadjuvant interferon-based chemoradiation for locally advanced pancreas cancer: A phase II pilot study.
Randomized, double-blind, placebo-controlled phase II study of AMG 386 combined with weekly paclitaxel in patients with recurrent ovarian cancer.
Summary report on the graded prognostic assessment: An accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases
Hormone receptor expression and risk of recurrence in patients with high-risk endometrial carcinoma treated with chemotherapy
Development and independent validation of a prognostic assay for stage ii colon cancer using formalin-fixed paraffin-embedded tissue
Post-traumatic stress symptoms in long-term non-Hodgkin's lymphoma survivors: Does time heal?
Mortality by stage for right- versus left-sided colon cancer: analysis of surveillance, epidemiology, and end results--Medicare data.
Phase III study of doxorubicin/cyclophosphamide with concomitant versus sequential docetaxel as adjuvant treatment in patients with human epidermal growth factor receptor 2-normal, node-positive breast cancer: BCIRG-005 trial
An update on the dosimetric analysis of concurrent radiation therapy and trastuzumab on early cardiac events.
Treatment-related changes in neurobehavioral symptoms.
Predicting chemotherapy toxicity in older adults with cancer: A prospective multicenter study
Occurrence of multiple subsequent neoplasms in long-term survivors of childhood cancer: A report from the childhood cancer survivor study
Comparison of high-dose methotrexate (HD-MTX) with Capizzi methotrexate plus asparaginase (C-MTX/ASNase) in children and young adults with high-risk acute lymphoblastic leukemia (HR-ALL): A report from the Children's Oncology Group Study AALL0232.
Phase II study of cetuximab in combination with chemoradiation in patients with stage IIIA/B non-small-cell lung cancer: RTOG 0324
A phase II study of daily afatinib (BIBW 2992) with or without temozolomide (21/28 days) in the treatment of patients with recurrent glioblastoma.
Long-term follow-up of dose-dense neoadjuvant chemotherapy in patients with stage II/III breast cancer.
Glioma-associated oncogene family zinc finger 1 expression and metastasis in patients with head and neck squamous cell carcinoma treated with Radiation Therapy (RTOG 9003)
TET2 mutations improve the new European LeukemiaNet risk classification of acute myeloid leukemia: A cancer and leukemia group B study
Efficacy and rectal toxicity of hypofractionated radiation therapy with daily image guidance.
The reality of pancreas cancer care from access to delivery.
Phase III comparison of prophylactic cranial irradiation versus observation in patients with locally advanced non-small-cell lung cancer: Primary analysis of Radiation Therapy Oncology Group study RTOG 0214
Phase III trial of prophylactic cranial irradiation compared with observation in patients with locally advanced non-small-cell lung cancer: Neurocognitive and quality-of-life analysis
Analysis of the role of hematopoietic stem-cell transplantation in infants with acute lymphoblastic leukemia in first remission and mll gene rearrangements: A report from the children's oncology group
Racial and ethnic disparities in risk and survival in children with neuroblastoma: A children's oncology group study
Prognostic significance of expression of a single microRNA, miR-181a, in cytogenetically normal acute myeloid leukemia: A cancer and leukemia group B study
Capacity to consent to research participation in adults with malignant glioma
IDH1 and IDH2 gene mutations identify novel molecular subsets within de novo cytogenetically normal acute myeloid leukemia: A cancer and leukemia group B study
Ofatumumab as single-agent CD20 immunotherapy in fludarabine-refractory chronic lymphocytic leukemia
Favorable Prognostic Impact of NPM1 Mutations in Older Patients with Cytogenetically Normal de Novo Acute Myeloid Leukemia and Associated Gene- And MicroRNA-Expression Signatures: A Cancer and Leukemia Group B Study
Phase II study of clofarabine monotherapy in previously untreated older adults with acute myeloid leukemia and unfavorable prognostic factors
Improved early event-free survival with imatinib in Philadelphia chromosome - Positive acute lymphoblastic leukemia: A Children's Oncology Group Study
Multicenter randomized phase II study of weekly or twice-weekly bortezomib plus rituximab in patients with relapsed or refractory follicular or marginal-zone B-cell lymphoma
High-dose imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: High rates of rapid cytogenetic and molecular responses
Predictive capacity of three comorbidity indices in estimating mortality after surgery for colon cancer
Prognostic importance of MN1 transcript levels, and biologic insights from MN1-associated gene and microRNA expression signatures in cytogenetically normal acute myeloid leukemia: A cancer and leukemia group B study
A phase I evaluation of intravenous (IV) (131)I-chlorotoxin delivery to solid peripheral and intracranial tumors.
A phase I evaluation of intravenous TM601 in recurrent glioblastoma: Use of perfusion MRI to monitor antiangiogenic effects.
A phase I study of ABT 510 and concurrent temozolamide and radiotherapy for patients with newly diagnosed glioblastoma multiforme.
A phase I trial of sns-314, a novel and selective pan-aurora kinase inhibitor, in advanced solid tumor patients.
Challenges for retrospective cohort studies: A profile of patients who refuse participation or are lost to follow-up.
Current survival statistics for patients with newly diagnosed glioblastoma treated with radiation and temozolomide on research studies in the United States.
Detection of Merkel cell polyomavirus in formalin-fixed, paraffin-embedded tissue of Merkel cell carcinoma and its correlation with prognosis.
Differential survival after prostate cancer by race: Role of NCI-designated comprehensive cancer centers.
Dosimetry study of a phase II multiple-dose intracavitary administration of (131)I-TM601 in adult patients with recurrent high-grade glioma.
Feasibility and phase I trial of tandutinib in patients with recurrent glioblastoma.
In vitro chemoresponse assay results and population chemotherapy response rates in endometrial cancer.
NABTT 0306: A randomized phase II trial of EMD 121974 in conjunction with concomitant and adjuvant temozolomide with radiation therapy in patients with newly diagnosed glioblastoma multiforme (GBM).
NABTT-0702: A phase II study of R-(-)-gossypol (AT-101) in recurrent glioblastoma multiforme (GBM).
Prognostic significance of VDR, DKK-1, and DKK-4 expression in colorectal cancer.
Recommendation of adjuvant chemotherapy and trastuzumab in older adults with HER2-positive breast cancer: A survey of oncologists.
Role of IκBα as a negative regulator of EGFR and a molecular determinant of prognosis in glioblastoma multiforme.
Treatment of recurrent malignant glioma with G207, a genetically engineered herpes simplex virus-1, followed by irradiation: Phase I study results.
Health behaviors influence cancer survival
Accelerated telomere shortening precedes development of therapy-related myelodysplasia or acute myelogenous leukemia after autologous transplantation for lymphoma
Late congestive heart failure after hematopoietic cell transplantation
Randomized phase II study of cilengitide, an integrin-targeting arginine-glycine-aspartic acid peptide, in recurrent glioblastoma multiforme
Reirradiation and concurrent chemotherapy after salvage surgery: Pay now or pay later
Role of age and health in treatment recommendations for older adults with breast cancer: The perspective of oncologists and primary care providers
Remission after radiotherapy for a patient with chemotherapy-refractory HIV-associated primary effusion lymphoma
Prognostic significance of, and gene and MicroRNA expression signatures associated with, CEBPA mutations in cytogenetically normal acute myeloid leukemia with high-risk molecular features: A cancer and leukemia group B study
Phase II trial of sorafenib in advanced thyroid cancer
Wilms' tumor 1 gene mutations independently predict poor outcome in adults with cytogenetically normal acute myeloid leukemia: A cancer and leukemia group B study
Phase II study of palifermin and concurrent chemoradiation in head and neck squamous cell carcinoma
Effect of TRA-8 anti-DR5 monoclonal antibody in combination with chemotherapy in an ex vivo human ovarian cancer model.
Stage-specific survival differences associated with postoperative radiotherapy for gastrointestinal cancers
Short preoperative treatment with erlotinib inhibits tumor cell proliferation in hormone receptor-positive breast cancers
Osteosarcoma: The addition of muramyl tripeptide to chemotherapy improves overall survival - A report from the children's oncology group
Move onward, press forward, and take a deep breath: Can lifestyle interventions improve the quality of life of women with breast cancer, and how can we be sure?
Biology of interactions: Antiepidermal growth factor receptor agents
High expression levels of the ETS-related gene, ERG, predict adverse outcome and improve molecular risk-based classification of cytogenetically normal acute myeloid leukemia: A cancer and leukemia group B study
Results of a phase II study of high-dose thoracic radiation therapy with concurrent cisplatin and etoposide in limited-stage small-cell lung cancer (NCCTG 95-20-53)
Main outcomes of the FRESH START trial: A sequentially tailored, diet and exercise mailed print intervention among breast and prostate cancer survivors
Quality of life in head and neck cancer patients after treatment with high-dose radiotherapy alone or in combination with cetuximab
Lessons learned in the management of advanced pancreatic cancer
Phase I and correlative biology study of cilengitide in patients with recurrent malignant glioma
Double-blinded randomized study of high-dose calcitriol plus docetaxel compared with placebo plus docetaxel in androgen-independent prostate cancer: A report from the ASCENT investigators
Interpreting the economic literature in oncology
Clinical cancer advances 2006: Major research advances in cancer treatment, prevention, and screening - A report from the American Society of Clinical Oncology
Significance of necrosis in grading of oligodendroglial neoplasms: A clinicopathologic and genetic study of newly diagnosed high-grade gliomas
Promoting health and physical function among cancer survivors: Potential for prevention and questions that remain
Randomized phase II study of bortezomib alone and bortezomib in combination with docetaxel in previously treated advanced non-small-cell lung cancer
Disadvantage of men living alone participating in radiation therapy oncology group head and neck trials
Adverse prognostic significance of KIT mutations in adult acute myeloid leukemia with inv(16) and t(8;21): A Cancer and Leukemia Group B study
Cancer survival: Time to get moving? Data accumulate suggesting a link between physical activity and cancer survival
Phase I single-dose study of intracavitary-administered iodine-131-TM-601 in adults with recurrent high-grade glioma
Lifestyle intervention development study to improve physical function in older adults with cancer: Outcomes from project LEAD
Postoperative radiotherapy in non-small-cell lung cancer warrants further exploration in the era of adjuvant chemotherapy and conformal radiotherapy
A novel low molecular weight inhibitor of focal adhesion kinase and insulin-like growth factor-1 receptor, TAE226, inhibits glioma growth.
An IMRT technique to increase therapeutic ratio of breast irradiation in patients with early stage left breast cancer: Limiting second malignancies.
Effects of depression on quality of life in Medicare beneficiaries with prostate cancer.
Ex vivo activation and expansion of γδ T cells for immunotherapy of glioblastoma.
Phenotypic expression of Bax is a predictive marker of 5-fluorouracil treatment in colorectal cancer.
Polymorphisms in candidate genes in patients with congestive heart failure (CHF) after childhood cancer: A Report from the Childhood Cancer Survivor Study (CCSS).
Prospective multi-institutional study of reverse transcriptase polymerase chain reaction for molecular staging of melanoma
Results of FRESH START: A randomized controlled trial to improve diet and exercise behaviors in breast and prostate cancer survivors.
Results of FRESH START: A randomized controlled trial to improve diet and exercise behaviors in breast and prostate cancer survivors.
Safety and effectiveness of dose dense neoadjuvant chemotherapy in patients with stage II/III breast cancer.
Safety and tolerance of multiple weekly intracavitary injections of 131I-chlorotoxin (TM-601): Preliminary results of a prospective clinical trial in patients with recurrent glioblastoma multiforme.
Solid organ second malignant neoplasms among children diagnosed with malignant bone tumors treated on Children Cancer Study Group/Pediatric Oncology Group protocols after 1980.
Tumor necrosis factor-α-induced protein 3 down-regulates nuclear factor-κB-mediated drug resistance in vitro and is a favorable clinical prognostic factor in human glioblastomas.
Use of complementary and alternative medicine and spiritual practices among women with ovarian carcinoma in the southeastern United States.
Visual complications in childhood cancer survivors: A Childhood Cancer Survivor Study report.
Phase II multicenter study of arsenic trioxide in patients with myelodysplastic syndromes
Geriatric syndromes in elderly patients admitted to an oncology-acute care for elders unit
Impact of IGF-I and CYP19 Gene Polymorphisms on the Survival of Patients With Metastatic Prostate Cancer
Tumor necrosis factor-α-induced protein 3 as a putative regulator of nuclear factor-κB-mediated resistance to O
-alkylating agents in human glioblastomas
Concomitant boost radiation plus concurrent cisplatin for advanced head and neck carcinomas: Radiation Therapy Oncology Group Phase II Trial 99-14
In reply 
Osteosarcoma: A randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate
Outcome of induction and postremission therapy in younger adults with acute myeloid leukemia with normal karyotype: A cancer and leukemia group B study
Overexpression of the ETS-related gene, ERG, predicts a worse outcome in acute myeloid leukemia with normal karyotype: A Cancer and Leukemia Group B study
Phase I study of capecitabine with concomitant radiotherapy for patients with locally advanced pancreatic cancer: Expression analysis of genes related to outcome
Phase I/IIa study of cetuximab with gemcitabine plus carboplatin in patients with chemotherapy-naïve advanced non-small-cell lung cancer
Prognostic factors and outcome of core binding factor acute myeloid leukemia patients with t(8;21) differ from those of patients with inv(16): A Cancer and Leukemia Group B study
Quality of life of long-term survivors of breast cancer and lymphoma treated with standard-dose chemotherapy or local therapy
Riding the crest of the teachable moment: Promoting long-term health after the diagnosis of cancer
Uncommon malignancies: Case 2. Gastric choriocarcinoma
Longitudinal assessment of hematopoietic abnormalities after autologous hematopoietic cell transplantation for lymphoma
Phase I/IIa study of cisplatin and gemcitabine as induction chemotherapy followed by concurrent chemoradiotherapy with gemcitabine and paclitaxel for locally advanced non-small-cell lung cancer
Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer/International Union Against Cancer stage III and IV nasopharyngeal cancer of the endemic variety
Feasibility of hand-assisted laparoscopic surgery (HALS) in gynecologic oncology patients.
Results of Project LEAD (Leading the Way in Exercise and Diet) - A trial testing an intervention of telephone-counseling and mailed materials in improving physical functioning among older breast and prostate cancer survivors
Results of Project LEAD (Leading the Way in Exercise and Diet) - A trial testing an intervention of telephone-counseling and mailed materials in improving physical functioning among older breast and prostate cancer survivors.
TRAIL death receptor therapy for malignant glioma.
TRAIL-mediated induction of apoptosis as a targeted therapy for prostate cancer.
Development of risk-based guidelines for pediatric cancer survivors: The Children's Oncology Group Long-Term Follow-Up Guidelines from the Children's Oncology Group Late Effects Committee and Nursing Discipline
Abnormal cytogenetics at date of morphologic complete remission predicts short overall and disease-free survival, and higher relapse rate in adult acute myeloid leukemia: Results from Cancer and Leukemia Group B study 8461
Individualized patient dosing in phase I clinical trials: The role of Escalation with Overdose Control in PNU-214936
Preliminary results of Radiation Therapy Oncology Group 97-03: A randomized phase II trial of concurrent radiation and chemotherapy for advanced squamous cell carcinomas of the head and neck
Repetitive cycles of high-dose cytarabine benefit patients with acute myeloid leukemia and inv(16)(p13q22) or t(16;16)(p13;q22): Results from CALGB 8461
Safety of treatment of metastatic breast cancer with trastuzumab beyond disease progression
Understanding cancer treatment and outcomes: The cancer care outcomes research and surveillance consortium
Detection of disseminated breast cancer growth and treatment response using non-invasive bioluminescence imaging.
Feasibility study of liposomal doxorubicin consolidation therapy after platinum/paclitaxel-based chemotherapy for suboptimally debulked stage IIIC/IV ovarian cancer patients.
Poor prognosis of taxane/platinum treated advanced stage ovarian cancer patients despite a negative second look laparotomy.
UAB's experience with concurrent capecitabine (CAP) and radiotherapy (RT) in Pts with resected (RES) or locally advanced (LA) pancreatic cancer (Pan Ca).
High risk of subsequent neoplasms continues with extended follow-up of childhood Hodgkin's disease: Report from the Late Effects Study Group
Prognostic characteristics of breast cancer among postmenopausal hormone users in a screened population
Health status and quality of life in patients with early-stage Hodgkin's disease treated on Southwest Oncology Group Study 9133
The outcome of combined-modality therapy for stage III non-small-cell lung cancer in the elderly
The Minneapolis-Manchester quality of life instrument: Reliability and validity of the adolescent form
Revision of the American Joint Committee on cancer staging system for breast cancer
Nutrition and survival after the diagnosis of breast cancer: A review of the evidence
Treatment with ibritumomab tiuxetan radioimmunotherapy in patients with rituximab-refractory follicular non-Hodgkin's lymphoma
Adjuvant radiation therapy after complete resection of non-small-cell lung cancer  (multiple letters)
Phase II/III trial of etoposide and high-dose ifosfamide in newly diagnosed metastatic osteosarcoma: A pediatric oncology group trial
Neuropsychologic impact of standard dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma
Balancing the possible effectiveness of postoperative radiotherapy for non-small-cell lung cancer against the possible detriment of radiation-induced toxicity
Pivotal study of iodine I 131 tositumomab for chemotherapy-refractory low-grade or transformed low-grade B-cell non-Hodgkin's lymphomas
Prognostic factors analysis of 17,600 melanoma patients: Validation of the American Joint Committee on Cancer melanoma staging system
Is there an association between total-body irradiation and secondary acute myelogenous leukemia/myelodysplastic syndrome in patients with relapsed/refractory Hodgkin's disease treated with autologous stem-cell transplantation?  (multiple letters)
Phase I study of anti-epidermal growth factor receptor antibody cetuximab in combination with radiation therapy in patients with advanced head and neck cancer
Changes in weight, body composition, and factors influencing energy balance among premenopausal breast cancer patients receiving adjuvant chemotherapy
Comparison of cytogenetic and molecular genetic detection of t(8;21) and inv(16) in a prospective series of adults with de novo acute myeloid leukemia: A cancer and leukemia group B study
Chemotherapy for human immunodeficiency virus-associated non-Hodgkin's lymphoma in combination with highly active antiretroviral therapy
Solid cancers after bone marrow transplantation
BR96-doxorubicin: Been there, done that!  (multiple letters)
Enhanced apoptosis with combination C225/radiation treatment serves as the impetus for clinical investigation in head and neck cancers.
Multicenter phase II study of iodine-131 tositumomab for chemotherapy- relapsed/refractory low-grade and transformed low-grade B-cell non-Hodgkin's lymphomas
Phase I trial of the anti-Lewis Y drug immunoconjugate BR96-doxorubicin in patients with Lewis Y-expressing epithelial tumors
Massage therapy for patients undergoing autologous bone marrow transplant
Childhood acute lymphoblastic leukemia with the MLL-ENL fusion and t(11;19)(q23;p13.3) Translocation
Patients with t(8;21)(q22;q22) and acute myeloid leukemia have superior failure-free and overall survival when repetitive cycles of high-dose cytarabine are administered
Phase III comparison of twice-daily split-course irradiation versus once-daily irradiation for patients with limited stage small-cell lung carcinoma
Randomized phase II study of BR96-doxorubicin conjugate in patients with metastatic breast cancer
Treatment of patients with low-grade B-cell lymphoma with the combination of chimeric anti-CD20 monoclonal antibody and CHOP chemotherapy
Consolidation therapy with antimetabolite-based therapy in standard- risk acute lymphocytic leukemia of childhood: A pediatric oncology group study
Maximum-tolerated dose, toxicity, and efficacy of
I-Lym-1 antibody for fractionated radioimmunotherapy of non-Hodgkin's lymphoma
Meta-analysis of chemotherapy versus combined modality treatment trials in Hodgkin's disease
Prognostic significance of sex in childhood B-precursor acute lymphoblastic leukemia: A pediatric oncology group study
Second cancers after pediatric Hodgkin's disease  (multiple letters)
Assessment of genomic damage in colorectal cancer by DNA fingerprinting: Prognostic applications
Association of local recurrence with subsequent survival in extremity soft tissue sarcoma
Brain tumor-polyposis syndrome: Two genetic diseases?
Extramedullary leukemia adversely affects hematologic complete remission rate and overall survival in patients with t(8;21)(q22;q22): Results from Cancer and Leukemia Group B 8461
Paclitaxel and concurrent radiation for locally advanced pancreatic and gastric cancer: A phase I study
Phase II trial of docetaxel in non-Hodgkin's lymphomas: A study of the cancer and leukemia group B
Prognostic factors associated with long-term survival for retroperitoneal sarcoma: Implications for management
Secondary cytogenetic changes in acute promyelocytic leukemia - Prognostic importance in patients treated with chemotherapy alone and association with the intron 3 breakpoint of the PML gene: A Cancer and Leukemia Group B study
Chemotherapy followed by accelerated fractionated radiation for larynx preservation in patients with advanced laryngeal cancer
Improved survival for children with B-cell acute lymphoblastic leukemia and stage IV small noncleaved-cell lymphoma: A Pediatric Oncology Group study
Prognostic significance of a positive microscopic margin in high-risk extremity soft tissue sarcoma: Implications for management
Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia
Prognostic value of p53 nuclear overexpression in patients with invasive bladder cancer treated with neoadjuvant MVAC
Effect of a National Cancer Institute Clinical Alert on breast cancer practice patterns
Limited-stage small-cell lung cancer: Patterns of intrathoracic recurrence and the implications for thoracic radiotherapy
Phase I trial of dacarbazine with cyclophosphamide, carmustine, etoposide, and autologous stem-cell transplantation in patients with lymphoma and multiple myeloma
Combination chemotherapy with or without thoracic radiotherapy in limited-stage small-cell lung cancer: A randomized trial of the southeastern cancer study group
Immunophenotypes and karyotypes of leukemic cells in children with down syndrome and acute lymphoblastic leukemia
Stage III neuroblastoma over 1 year of age at diagnosis: Improved survival with intensive multimodality therapy including multiple alkylating agents
Why women gain weight with adjuvant chemotherapy for breast cancer
Preradiation intracarotid cisplatin treatment of newly diagnosed anaplastic gliomas. The CNS Cancer Consortium.
A phase III trial comparing idarubicin and daunorubicin in combination with cytarabine in acute myelogenous leukemia: A Southeastern Cancer Study Group study
Ploidy of lymphoblasts is the strongest predictor of treatment outcome in b-progenitor cell acute lymphoblastic leukemia of childhood: A pediatric oncology group study
Preradiation intracarotid cisplatin treatment of newly diagnosed anaplastic gliomas
Treatment of children with progressive or recurrent brain tumors with carboplatin or iproplatin: A Pediatric Oncology Group randomized phase II study
Corynebacterium parvum versus bacille calmette-guérin adjuvant immunotherapy of stage II malignant melanoma
Prognostic significance of CD34 expression in childhood B-precursor acute lymphocytic leukemia: A pediatric oncology group study
Randomized comparison of two combination regimens versus minimal chemotherapy in nonsmall-cell lung cancer: A Southeastern Cancer Study Group trial
Phase II treatment of medulloblastoma and pineoblastoma with melphalan: Clinical therapy based on experimental models of human medulloblastoma
A randomized comparison of haloperidol plus dexamethasone versus prochlorperazine plus dexamethasone in preventing nausea and vomiting in patients receiving chemotherapy for breast cancer
Clinical use of a standard kit-preparation of radiolabeled monoclonal antibody 96.5 in the diagnostic imaging of metastatic melanoma
Consolidation and maintenance therapy in multiple myeloma: Randomized comparison of a new approach to therapy after initial response to treatment
Ewing's sarcoma in bones of the hands and feet: A clinicopathologic study and review of the literature
Phase III study of BCOP v CHOP in unfavorable categories of malignant lymphoma: A Southeastern Cancer Study Group Trial
Randomized phase III comparison of three doxorubicin-based chemotherapy regimens in advanced non-small cell lung cancer: A Southeastern Cancer Study Group trial
A multifactorial analysis of prognostic factors in patients with liver metastases from colorectal carcinoma.
International Standard Serial Number (issn)
Electronic International Standard Serial Number (eissn)